Skip to main content
Premium Trial:

Request an Annual Quote

Biocartis, Fast-track Diagnostics to Co-Develop Infectious Disease Assays

NEW YORK (GenomeWeb) – Biocartis and Fast-track Diagnostics announced on Wednesday that they have formed a strategic collaboration to develop a range of multiplex tests for infectious diseases.

Under the arrangement, the companies will develop tests based on Fast-track's PCR-based infectious disease menu for use on Biocartis' Idylla automated molecular diagnostics platform. The first assay to be developed is expected to be a multiplex respiratory panel for the detection of viral and bacterial targets in upper respiratory tract infections.

Additional terms of the deal were not disclosed.

"By combining Fast-track Diagnostics' expertise and compelling portfolio of multiplex PCR panels with the multiplex capabilities and unique features of our Idylla system, we have formed a powerful combination to create tests that can identify multiple disease-driving pathogens from a patient sample," Erik Vossenaar, vice president of business development at Biocartis, said in a statement.

The Scan

Pig Organ Transplants Considered

The Wall Street Journal reports that the US Food and Drug Administration may soon allow clinical trials that involve transplanting pig organs into humans.

'Poo-Bank' Proposal

Harvard Medical School researchers suggest people should bank stool samples when they are young to transplant when they later develop age-related diseases.

Spurred to Develop Again

New Scientist reports that researchers may have uncovered why about 60 percent of in vitro fertilization embryos stop developing.

Science Papers Examine Breast Milk Cell Populations, Cerebral Cortex Cellular Diversity, Micronesia Population History

In Science this week: unique cell populations found within breast milk, 100 transcriptionally distinct cell populations uncovered in the cerebral cortex, and more.